Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
60 seconds · no obligationView Profile
Cervical cancer is a malignancy originating in the cells lining the cervix, the lower part of the womb. Women often contact a doctor following abnormal vaginal bleeding, unusual discharge, or pelvic discomfort, though early stages may produce no noticeable signs. The available treatment options depend on a specialist assessment and detailed staging investigations. Compare hospitals in Turkey that treat Cervical Cancer and get a free review of your medical records.

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
OncologyVerified
English · Turkish
60 seconds · no obligationView Profile
Cervical cancer is a malignancy originating in the cells lining the cervix, the lower part of the womb. Women often contact a doctor following abnormal vaginal bleeding, unusual discharge, or pelvic discomfort, though early stages may produce no noticeable signs. The available treatment options depend on a specialist assessment and detailed staging investigations.
Specialty: Oncology
Depending on the stage and your medical history, doctors may recommend:
The cost of treating Cervical Cancer depends on the diagnosis and the treatment chosen. Doctors first review your medical records — free of charge — and you then receive an itemised quote.
Options may include Radiotherapy for Cervical Cancer, Chemotherapy for Cervical Cancer, Complex Diagnostics of Cervical Cancer, Brachytherapy for Cervical Cancer. Your doctor chooses the approach after reviewing your tests and scans.
Cervical Cancer is treated by Oncology specialists. 2 clinics in Turkey on our platform offer this treatment.
Cervical cancer arises in the cells lining the cervix, the lower segment of the uterus opening into the vagina. Persistent infection with high-risk human papillomavirus (HPV) strains, particularly HPV-16 and HPV-18, causes the vast majority of cases. Most tumours originate as squamous cell carcinomas in the transformation zone, while a smaller proportion develop as adenocarcinomas in glandular cells.
Early-stage cervical neoplasia often develops without noticeable warning signs. As malignant cells invade deeper cervical stroma, symptoms emerge. Patients visiting a specialist in gynaecology commonly report:
Accurate staging guides all oncological decision-making. When you arrive at a hospital in Turkey, multidisciplinary teams evaluate tumour size, depth of stromal invasion, parametrial involvement, and lymph node status using the FIGO (International Federation of Gynaecology and Obstetrics) system.
Clinical evaluation relies on comprehensive check-ups and diagnostics to determine cancer spread. Hospital evaluations typically include:
Patients should bring their original pathology reports, paraffin-embedded tissue blocks or unstained glass slides, previous pelvic imaging on CD or DICOM format, and relevant surgical or screening summaries.
Therapeutic strategies depend on disease stage, histological characteristics, general health, and whether you wish to preserve fertility. Clinical decisions are made by treating doctors in specialised oncology units following diagnostic verification.
| Option | Typically used when | Things to know |
|---|---|---|
| Fertility-sparing surgery | Microscopic or small early-stage tumours (FIGO IA to small IB1) without lymph node spread. | Procedures like conisation or radical trachelectomy remove malignant tissue while preserving the womb. Often planned alongside IVF and fertility specialists. |
| Radical hysterectomy | Early-stage disease (FIGO IA2 to IB2) when fertility preservation is not needed. | Removes the uterus, cervix, parametrium, upper vagina, and pelvic lymph nodes. Requires surgical hospitalisation and recovery. |
| Chemoradiotherapy (CCRT) | Locally advanced tumours (FIGO IB3 to IVA) or high-risk post-surgical pathology. | Combines external beam radiation with weekly cisplatin chemotherapy, followed by brachytherapy (internal radiation) directed at the tumour site. |
| Systemic therapy | Metastatic (FIGO IVB) or recurrent cancer unsuitable for local treatments. | Uses platinum chemotherapy regimens, often combined with targeted therapies or immunotherapy, to manage symptoms and halt tumour progression. |
Following primary treatment, specialised rehabilitation helps address pelvic floor recovery, sexual health adjustments, and lower-limb lymphedema prevention.
Organising oncological treatment abroad requires careful planning. Before travel, international hospital coordination teams review your diagnostic reports and medical history to provide a provisional clinical roadmap.
Your length of stay in Turkey depends on the recommended treatment modality:
Before flying home, your hospital provides full discharge summaries, surgical records, radiation dose plans, and pathology reports. Establishing clear communication between your Turkish care team and your local oncologist ensures smooth ongoing surveillance and timely management of any delayed side effects.
Air travel places physiological strain on the body, increasing dehydration and the risk of venous thromboembolism. Certain acute symptoms make long-distance transit unsafe.
Do not travel, and seek immediate emergency care locally, if you develop:
Your treating physician must assess your individual medical stability and confirm fitness to fly before any international travel takes place.
Fertility-sparing options, such as a conisation or radical trachelectomy, may be considered for small, early-stage tumours when cancer has not spread to the parametrium or lymph nodes. The cervix and upper vagina are removed while the body of the uterus is preserved. Your oncologist and gynaecological surgeon determine suitability after reviewing detailed pelvic MRI scans and histological margins.
Surgery is primarily utilised for early-stage cervical cancer where the tumour is confined to the cervix. For locally advanced tumours that have spread into surrounding tissues or pelvic lymph nodes, definitive chemoradiotherapy is standard. This treatment combines external radiation and low-dose chemotherapy with brachytherapy, delivering concentrated radiation directly to the tumour while sparing healthy surrounding pelvic structures.
You should bring your original histopathology report, formal biopsy review documents, and physical paraffin tissue blocks or unstained glass slides for laboratory verification. Additionally, bring digital copies of all pelvic MRI, CT, or PET-CT scans on disc, alongside medical notes detailing past gynaecological surgeries or screening results. Having original materials prevents diagnostic delays and unnecessary repeat procedures.
The length of your stay depends on the chosen treatment approach. Patients undergoing surgical treatment typically stay in Turkey for 10 to 18 days to complete pre-operative preparation, surgery, and post-operative monitoring. If your medical team recommends definitive concurrent chemoradiotherapy, expect to stay for five to seven weeks to complete daily external beam radiation sessions alongside brachytherapy treatments.
Before you leave Turkey, your medical team provides detailed clinical documentation, including operative reports, radiation plans, and imaging discs. You will share these records with your oncologist or gynaecologist at home to continue scheduled surveillance. Follow-up visits usually occur every three to four months for the first two years, incorporating physical examinations, pelvic checks, and periodic imaging.
Your request is in!
Your coordinator will contact you — usually within 2 hours, 24/7.
Want a faster, more accurate assessment?
Add photos & medical detailsLeave your number — a coordinator calls you in your language, usually within 15 minutes during office hours.
Thank you!
A coordinator will contact you at the time you chose.